Elagolix

CHEMBL1208155 Phase 4 Aprovado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

631.6 g/mol

LogP

2.6

Phase

4

This medication works by reducing the production of certain hormones that stimulate the growth of endometrial tissue outside the uterus. It helps relieve the pain associated with endometriosis.

Peso Molecular

631,6000 g/mol

LogP

2,60

TPSA

99,20 Å²

Regra dos 5 de Lipinski

Reprovado

Áreas Terapêuticas

Endometriosis

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

COc1cccc(-c2c(C)n(Cc3c(F)cccc3C(F)(F)F)c(=O)n(C[C@H](NCCCC(=O)O)c3ccccc3)c2=O)c1F

InChI

InChI=1S/C32H30F5N3O5/c1-19-28(21-11-6-14-26(45-2)29(21)34)30(43)40(18-25(20-9-4-3-5-10-20)38-16-8-15-27(41)42)31(44)39(19)17-22-23(32(35,36)37)12-7-13-24(22)33/h3-7,9-14,25,38H,8,15-18H2,1-2H3,(H,41,42)/t25-/m0/s1

Molecular Formula

C32H30F5N3O5

HBD / HBA

2 / 11

Ligações Rotacionáveis

12

Átomos Pesados

45

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

This medication works by reducing the production of certain hormones that stimulate the growth of endometrial tissue outside the uterus. It helps relieve the pain associated with endometriosis.

Yes, Elagolix is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1208155. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 11250647. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Procura informações acessíveis para o paciente?

Elagolix no PillFYI

Estrutura

Dados Rápidos

Fórmula: C32H30F5N3O5
Sinônimos: 2

Links Externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.